628 related articles for article (PubMed ID: 31354245)
1. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M
Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245
[No Abstract] [Full Text] [Related]
2. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.
Lin BW; Huang WL; Wang L; Chen ZM
J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093
[TBL] [Abstract][Full Text] [Related]
6. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
Kim EC; Choi JS; Joo CK
Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
[TBL] [Abstract][Full Text] [Related]
7. Topical insulin for refractory persistent corneal epithelial defects.
Abdi P; Ghaffari R; Azad N; Alshaheeb A; Latifi G; Soltani Shahgoli S; Fakhredin H
Sci Rep; 2024 May; 14(1):12459. PubMed ID: 38816428
[TBL] [Abstract][Full Text] [Related]
8. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
9. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine.
Iaccheri B; Torroni G; Cagini C; Fiore T; Cerquaglia A; Lupidi M; Cillino S; Dua HS
Eye (Lond); 2017 May; 31(5):788-794. PubMed ID: 28157225
[TBL] [Abstract][Full Text] [Related]
10. Topical insulin, a novel corneal epithelial regeneration agent in dry eye disease.
Burgos-Blasco B; Diaz-Valle D; Rego-Lorca D; Perez-Garcia P; Puebla-Garcia V; Fernandez-Vigo JI; Benitez-Del-Castillo JM; Gegundez-Fernandez JA
Eur J Ophthalmol; 2024 May; 34(3):719-725. PubMed ID: 37814519
[TBL] [Abstract][Full Text] [Related]
11. Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery.
Lekhanont K; Jongkhajornpong P; Choubtum L; Chuckpaiwong V
Biomed Res Int; 2013; 2013():521315. PubMed ID: 23984378
[TBL] [Abstract][Full Text] [Related]
12. Effects of artificial tear treatment on corneal epithelial thickness and corneal topography findings in dry eye patients.
Çakır B; Doğan E; Çelik E; Babashli T; Uçak T; Alagöz G
J Fr Ophtalmol; 2018 May; 41(5):407-411. PubMed ID: 29776765
[TBL] [Abstract][Full Text] [Related]
13. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
Jirsova K; Brejchova K; Krabcova I; Filipec M; Al Fakih A; Palos M; Vesela V
Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis.
Wan KH; Chen LJ; Young AL
Ocul Surf; 2015 Jul; 13(3):213-25. PubMed ID: 26045239
[TBL] [Abstract][Full Text] [Related]
15. Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects.
Yamada N; Morishige N; Yanai R; Morita Y; Kimura K; Chikama T; Nomizu M; Sonoda KH; Nishida T
Cornea; 2012 Dec; 31(12):1408-13. PubMed ID: 23135532
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of rb-bFGF Eye Drops for Post-Cataract Surgery Dry Eye and Observation of Changes in Tear Secretion and Corneal Damage in Patients.
Zhao X; Jia Q; Fu J
Altern Ther Health Med; 2023 Nov; 29(8):489-495. PubMed ID: 37652420
[TBL] [Abstract][Full Text] [Related]
17. Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief.
Huang HY; Wang MC; Chen ZY; Chiu WY; Chen KH; Lin IC; Yang WV; Wu CC; Tseng CL
Int J Nanomedicine; 2018; 13():7251-7273. PubMed ID: 30510416
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease.
Hardten DR; Brown MJ; Pham-Vang S
Curr Med Res Opin; 2007 Sep; 23(9):2083-91. PubMed ID: 17822610
[TBL] [Abstract][Full Text] [Related]
19. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
Sall K; Stevenson OD; Mundorf TK; Reis BL
Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
[TBL] [Abstract][Full Text] [Related]
20. Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
Zhang X; Lin X; Liu Z; Wu Y; Yang Y; Ouyang W; Li W; Liu Z
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6056-6064. PubMed ID: 29204644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
